These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8156978)

  • 21. Interactions between oxcarbazepine and conventional antiepileptic drugs in the maximal electroshock test in mice: an isobolographic analysis.
    Luszczki JJ; Borowicz KK; Swiader M; Czuczwar SJ
    Epilepsia; 2003 Apr; 44(4):489-99. PubMed ID: 12680997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical experience with oxcarbazepine.
    Gram L
    Epilepsia; 1994; 35 Suppl 3():S21-2. PubMed ID: 8156976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The anticonvulsant SGB-017 (ADCI) blocks voltage-gated sodium channels in rat and human neurons: comparison with carbamazepine.
    Sun L; Lin SS
    Epilepsia; 2000 Mar; 41(3):263-70. PubMed ID: 10714396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacokinetic variability of oxcarbazepine in epileptic patients].
    Viola MS; Bercellini MA; Saidón P; Rubio MC
    Medicina (B Aires); 2000; 60(6):914-8. PubMed ID: 11436701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transplacental passage of oxcarbazepine and its metabolites in vivo.
    Myllynen P; Pienimäki P; Jouppila P; Vähäkangas K
    Epilepsia; 2001 Nov; 42(11):1482-5. PubMed ID: 11879354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Action of carbamazepine on epileptiform activity of the verartidine model in CA1 neurons.
    Otoom SA; Alkadhi KA
    Brain Res; 2000 Dec; 885(2):289-94. PubMed ID: 11102583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacodynamic and pharmacokinetic characterization of interactions between levetiracetam and numerous antiepileptic drugs in the mouse maximal electroshock seizure model: an isobolographic analysis.
    Luszczki JJ; Andres MM; Czuczwar P; Cioczek-Czuczwar A; Ratnaraj N; Patsalos PN; Czuczwar SJ
    Epilepsia; 2006 Jan; 47(1):10-20. PubMed ID: 16417526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver enzyme induction and serum lipid levels after replacement of carbamazepine with oxcarbazepine.
    Isojärvi JI; Pakarinen AJ; Rautio A; Pelkonen O; Myllylä VV
    Epilepsia; 1994; 35(6):1217-20. PubMed ID: 7988514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of carbamazepine and oxcarbazepine on wild-type and mutant neuronal nicotinic acetylcholine receptors linked to nocturnal frontal lobe epilepsy.
    Di Resta C; Ambrosi P; Curia G; Becchetti A
    Eur J Pharmacol; 2010 Sep; 643(1):13-20. PubMed ID: 20561518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluctuations of 10-hydroxy-carbazepine during the day in epileptic patients.
    May TW; Rambeck B; Sälke-Kellermann A
    Acta Neurol Scand; 1996 Jun; 93(6):393-7. PubMed ID: 8836299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overview of the clinical pharmacokinetics of oxcarbazepine.
    Flesch G
    Clin Drug Investig; 2004; 24(4):185-203. PubMed ID: 17516704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diminished response of CA1 neurons to antiepileptic drugs in chronic epilepsy.
    Schaub C; Uebachs M; Beck H
    Epilepsia; 2007 Jul; 48(7):1339-50. PubMed ID: 17441992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eslicarbazepine and the enhancement of slow inactivation of voltage-gated sodium channels: a comparison with carbamazepine, oxcarbazepine and lacosamide.
    Hebeisen S; Pires N; Loureiro AI; Bonifácio MJ; Palma N; Whyment A; Spanswick D; Soares-da-Silva P
    Neuropharmacology; 2015 Feb; 89():122-35. PubMed ID: 25242737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allergy to carbamazepine: parallel in vivo and in vitro detection.
    Troost RJ; Van Parys JA; Hooijkaas H; van Joost T; Benner R; Prens EP
    Epilepsia; 1996 Nov; 37(11):1093-9. PubMed ID: 8917060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microsomal metabolism of carbamazepine and oxcarbazepine in liver and placenta.
    Myllynen P; Pienimäki P; Raunio H; Vähäkangas K
    Hum Exp Toxicol; 1998 Dec; 17(12):668-76. PubMed ID: 9988371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of oxcarbazepine and carbamazepine in human placenta.
    Pienimäki P; Lampela E; Hakkola J; Arvela P; Raunio H; Vähäkangas K
    Epilepsia; 1997 Mar; 38(3):309-16. PubMed ID: 9070593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxcarbazepine: a review of its use in children with epilepsy.
    Bang L; Goa K
    Paediatr Drugs; 2003; 5(8):557-73. PubMed ID: 12895138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbamazepine and topiramate modulation of transient and persistent sodium currents studied in HEK293 cells expressing the Na(v)1.3 alpha-subunit.
    Sun GC; Werkman TR; Battefeld A; Clare JJ; Wadman WJ
    Epilepsia; 2007 Apr; 48(4):774-82. PubMed ID: 17381447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does oxcarbazepine warrant therapeutic drug monitoring? A critical review.
    Bring P; Ensom MH
    Clin Pharmacokinet; 2008; 47(12):767-78. PubMed ID: 19026033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxcarbazepine: an update of its efficacy in the management of epilepsy.
    Wellington K; Goa KL
    CNS Drugs; 2001; 15(2):137-63. PubMed ID: 11460891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.